摘要
目的:临床研究提高肝硬化顽固性腹水疗效的方法。方法:选取2014年3月-2015年6月在本院住院的肝硬化顽固性腹水患者135例,所有患者符合美国肝病研究学会《2013年肝硬化腹水成人患者处理指南》、《2010版EASL肝硬化腹水指南解析》、《2015年国际腹水俱乐部共识建议:肝硬化患者急性肾损伤的诊断与管理》诊断标准,将其随机分为治疗组(采用气针疗法配合特色药物治疗)68例,对照组(采用特色药物治疗)67例。对照组采用我院中西医结合常规方法治疗,治疗组在对照组治疗基础上加用气针疗法,选用经穴和经外奇穴治疗。参考2012年中华中医药学会脾胃病分会《肝硬化腹水中医治疗规范专家共识意见》并结合我院诊疗规范进行观察。结果:治疗组治疗后临床缓解43例,占63.23%;显效12例,占17.64%;有效10例,占14.71%;无效3例,占4.42%;总有效率为95.58%。对照组治疗后临床缓解23例,占34.33%;显效13例,占19.40%;有效11例,占16.42%;无效20例,占29.85%;总有效率为70.15%。两组治疗前差异不明显(P>0.05),无统计学意义,治疗后治疗组治疗效果明显好于对照组(P<0.05),说明气针疗法可以显著提高疗效。结论:在中西医结合特色药物治疗基础上加用气针疗法治疗肝硬化顽固性腹水可以显著提高疗效。
Objective:To study the therapeutic method of TCM treatment on cirrhosis.Methods:135patients were randomly divided into the treatment group(took Qi acupuncture plus featured medicines)of68cases and control group(took featured medicine)of67cases.Results:43cases in the treatment group were treated well,accounting for63.23%;12cases were obviously effective,accounting for17.64%;10cases were effective,accounting for14.71%;3cases were invalid,accounting for4.42%;the total efficiency was95.58%.In the control group,23cases were treated well,accounting for34.33%;13cases were obviously effective,accounting for19.40%;11cases were effective,accounting for16.42%;20cases were invalid,accounting for29.85%;the total efficiency was70.15%.After treatment,the effect is significantly better than the control group(P<0.05);Qi acupuncture therapy can significantly improve curative effects.Conclusion:The integrative medicine plus Qi acupuncture on refractory ascites in cirrhosis can significantly improve the curative effects.
出处
《中医临床研究》
2017年第32期20-24,共5页
Clinical Journal Of Chinese Medicine
基金
河北省中医药管理局中医药类科研计划课题(编号:2014234)
关键词
气针疗法
特色药物治疗
肝硬化顽固性腹水
临床研究
Qi acupuncture therapy
Featured medicine
Cirrhosis stubborn ascites
Clinical research
